Opposition from Industry Continues Against Bill to Amend Drug Laws
The bill introduced to reform drug laws is facing opposition from the pharma and medical device sectors. Several suggestions have not been accepted.
Translated from the Hindi original · translation AI-generated
The proposed bill to amend drug laws is facing strong backlash from the pharmaceutical and medical device industry. Industry representatives claim that their suggestions have been ignored, raising their concerns. The bill plans to change several rules related to the sale and distribution of drugs. Experts believe that this could be challenging for the industry.